logo logo
  • SV
  • |
  • EN
  • Our services
    • Inify laboratory services
    • For urology
    • For pathology
    • Instructions
    • Request a presentation
  • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
  • Careers
  • News & events
    • Inify Laboratories news
    • Events
    • Newsletter
    • Publications & Presentations
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify Laboratories
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Investor relations & media
logo logo
  • Start
  • Our services
    • Inify laboratory services
    • For urology
    • For pathology
    • Instructions
    • Request a presentation
  • About us
    • About us
    • Prostate cancer diagnosis
    • Words from our CEO
    • Executive team
  • Newsroom
    • News
    • Events
    • Newsletter
    • Publications & Presentations
  • Careers
  • Investors
    • Investor news
    • Financial reports
    • Invest in Inify
    • Company overview
    • Corporate governance
    • Executive team
    • Board of directors
    • Sustainability
    • The share
    • Financial calendar
    • Contacts
    • Subscription
  • Contact us
    • Contact
    • Visit us
    • Investor relations & media
  • SV
  • |
  • EN

Inify’s first ultramodern laboratory on track

Financial reports, Investor News, News 2022-08-17
STOCKHOLM – August 17 2022 – Inify Laboratories, a company providing fully digitalized pathology laboratory services for cancer diagnostics, listed in June 2022 on the Euronext Growth in Oslo, is on […]
Read More

Inify Laboratories – Extended subscription period

Investor News, News 2022-05-30
STOCKHOLM – May 30th, 2022 Inify Laboratories AB has decided to extend the Subscription Period in the ongoing Subsequent Offering to 3 June 2022 at 16:30 hours (CEST). As a […]
Read More

Inify Laboratories – extra bolagsstämma 2022-05-09

Investor News, News 2022-05-09
STOCKHOLM – 9 maj 2022 Inify Laboratories har hållit en extra bolagsstämma den 9 maj 2022. Bifogat finns en sammanfattning av de beslut som fattades vid den extra bolagsstämman. Vänligen […]
Read More

Inify Laboratories – kallelse till extra bolagsstämma

Investor News, News, Uncategorized 2022-04-11
STOCKHOLM – 11 april 2022 Inify Laboratories bjuder härmed in sina aktieägare till en extra bolagsstämma den 9 maj 2022. Bifogat finns kallelse inklusive dagordning och information om hur man […]
Read More

Inify Laboratories AB becomes an independent company

Home, Investor News, News 2021-12-10
STOCKHOLM – December 10, 2021 – ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved […]
Read More

ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service

Home, Investor News, News 2021-11-15
ContextVision today announces that the Board of Directors of ContextVision has decided to make a strategic shift and focus its pathology business unit entirely on the establishment of an AI based pathology lab service.
Read More

Aiming to build the company’s first modern pathology lab

Financial reports, Home, Investor News, News 2021-10-21
ContextVision has decided to build its first fully digital pathology laboratory – thus confirming its strong dedication to advancing digitalization within pathology, for the best of both patients and the medical profession.
Read More

INIFY Prostate® shown to accurately outline suspicious prostate cancer in study with two prominent medical centers

Home, News 2021-10-18
ContextVision today announced that results from a US clinical evaluation were presented at the Pathology Visions Congress in Las Vegas, USA.
Read More

In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites

Home, News 2021-08-31
STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that results from FirstPath […]
Read More
  • Our services

    Inify Laboratory services

    For urology

    For pathology

    Request a presentation

  • Inify Laboratories

    News & Events

    Newsletter

    Publications & Presentations

    Career

     

  • For Investors

    Invest in Inify Laboratories

    Investor news

    Financial reports (ENG)

    Financial reports (SWE)

    Financial calender

    Sustainability

    The share

    Executive team

    Subscription

     

     

  • Contact us

    +46 (0)8 26 73 30

    Find Inify Laboratories

  • Social media

    LinkedIn

    Twitter

© Inify® Laboratories